Macrophage migration inhibitory factor in allergic rhinitis: Its identification in eosinophils at the site of inflammation

Annals of Otology, Rhinology and Laryngology

Volumn 113, Issue 3 I, 2004, Pages 205-209

  Nakamaru, Yuji ^a,b   Takagi, Dai ^a,b   Oridate, Nobuhiko ^a,b   Furuta, Yasushi ^a,b   Nishihira, Jun ^a,b   Fukuda, Satoshi ^a,b  

^a Hokkaido Univ Grad Sch of Med ^*

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Allergic rhinitis; Cytokine; Eosinophil; Macrophage migration inhibitory factor

Indexed keywords

MACROPHAGE MIGRATION INHIBITION FACTOR;

ADOLESCENT; ADULT; ALLERGIC RHINITIS; ARTICLE; ATOPY; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; MACROPHAGE MIGRATION INHIBITION; MALE; NASAL BIOPSY; NOSE MUCOSA; PATHOGENESIS; PRIORITY JOURNAL;

EID: 1542619549     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348940411300306     Document Type: Article

References (21)

1. Korsgren M, Persson CG, Sundler F, et al. Natural killer cells determine development of allergen-induced eosinophilic airway inflammation in mice. J Exp Med 1999;189:553-62.
2. Bloom BR, Bennett B. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 1966;153: 80-2.
3. Nishihira J. Novel pathophysiological aspects of macrophage migration inhibitory factor (review). Int J Mol Med 1998;2:17-28.
4. Bacher M, Metz CN, Calandra T, et al. An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc Natl Acad Sci U S A 1996;93:7849-54.
5. Sabroe I, Pease JE, Williams TJ. Asthma and MIF: innately Th1 and Th2. Clin Exp Allergy 2000;30:1194-6.
6. Shimizu T, Abe R, Ohkawara A, Nishihira J. Increased production of macrophage migration inhibitory factor by PBMCs of atopic dermatitis. J Allergy Clin Immunol 1999;104:659-64.
7. Yamaguchi E, Nishihira J, Shimizu T, et al. Macrophage migration inhibitory factor (MIF) in bronchial asthma. Clin Exp Allergy 2000;30:1244-9.
8. Ishikawa K, Oyama M, Okuda M, et al. Japanese Guidelines for Allergic Rhinitis. Tokyo, Japan: Life Science Medica, 1999.
9. Nakai Y, Ohashi Y, Kakinoki Y, et al. Allergen-induced mRNA expression of IL-5, but not of IL-4 and IFN-gamma, in peripheral blood mononuclear cells is a key feature of clinical manifestation of seasonal allergic rhinitis. Arch Otolaryngol Head Neck Surg 2000;126:992-6.
10. Kitaichi N, Kotake S, Mizue Y, et al. High-dose corticosteroid administration induces increase of serum macrophage migration inhibitory factor in patients with Vogt-Koyanagi-Harada's disease. Microbiol Immunol 2000;44:1075-7.
11. Nishihira J, Kuriyama T, Nishino H, Ishibashi T, Sakai M, Nishi S. Purification and characterization of human macrophage migration inhibitory factor: evidence for specific binding to glutathione and formation of subunit structure. Biochem Mol Biol Int 1993;31:841-50.
12. Kitaichi N, Kotake S, Sasamoto Y, et al. Prominent increase of macrophage migration inhibitory factor in the sera of patients with uveitis. Invest Ophthalmol Vis Sci 1999;40:247-50.
13. van Cauwenberge P, Bachert C, Passalacqua G, et al. Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology. Allergy 2000;55:116-34.
14. International Rhinitis Management Working Group. International Consensus Report on the diagnosis and management of rhinitis. Allergy 1994;49(suppl 19).
15. Hansen G, Berry G, DeKruyff RH, Umetsu DT. Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation. J Clin Invest 1999;103:175-83.
16. Simpson CR, Anderson WJ, Helms PJ, et al. Coincidence of immune-mediated diseases driven by Th1 and Th2 subsets suggests a common aetiology. A population-based study using computerized general practice data. Clin Exp Allergy 2002;32: 37-42.
17. Castro M, Chaplin DD, Walter MJ, Holtzman MJ. Could asthma be worsened by stimulating the T-helper type 1 immune response? Am J Respir Cell Mol Biol 2000;22:143-6.
18. Rossi AG, Haslett C, Hirani N, et al. Human circulating eosinophils secrete macrophage migration inhibitory factor (MIF). Potential role in asthma. J Clin Invest 1998;101:2869-74.
19. Shimizu T, Abe R, Ohkawara A, Mizue Y, Nishihira J. Macrophage migration inhibitory factor is an essential immunoregulatory cytokine in atopic dermatitis. Biochem Biophys Res Commun 1997;240:173-8.
20. Calandra T, Spiegel LA, Metz CN, Bucala R. Macrophage migration inhibitory factor is a critical mediator of the activation of immune cells by exotoxins of gram-positive bacteria. Proc Natl Acad Sci U S A 1998;95:11383-8.
21. Mitchell RA, Metz CN, Peng T, Bucala R. Sustained mitogen-activated protein kinase (MAPK) and cytoplasmic phospholipase A2 activation by macrophage migration inhibitory factor (MIF). Regulatory role in cell proliferation and glucocorticoid action. J Biol Chem 1999;274:18100-6.